Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Dimethyl Sulfoxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Radiodermatitis 1 Neoplasms, Squamous Cell 1 Melanoma 1 Immune System Diseases 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Trastuzumab 521 Paclitaxel 473 Cyclophosphamide 468 Docetaxel 412 Capecitabine 351 Letrozole 310 Fulvestrant 269 Doxorubicin 246 Tamoxifen 228 Carboplatin 224 Anastrozole 197 Radiotherapy 193 exemestane 186 Epirubicin 170 Bevacizumab 166 palbociclib 150 Lapatinib 145 Vinorelbine 143 pertuzumab 141 Gemcitabine 139 pembrolizumab 136 Surveys and Questionnaires 118 Exercise 111 Magnetic Resonance Spectroscopy 109 eribulin 103 Fluorouracil 101 Albumin-Bound Paclitaxel 100 Blood Specimen Collection 96 130-nm albumin-bound paclitaxel 91 Everolimus 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03716583 2021-09-10

MELADERM

Herlev Hospital

Phase 2 Completed

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡